Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04413357 · ClinicalTrials.gov registry record · NA
Glycemic Response in Persons with Type 2 Diabetes
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04413357 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 14 participants.
The verdict
NCT04413357, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This will be a randomized crossover design with nutrition supplement interventions.
Interventions
- OTHER Balanced Nutritional Drink
- OTHER Diabetes Specific, Balanced Nutritional Drink (DMA)
- OTHER Diabetes Specific, Balanced Nutritional Drink DMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-05-18 |
| Est. Completion | 2020-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04413357
The ClinicalTrials.gov registry entry for NCT04413357 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Balanced Nutritional Drink is the first listed.
NCT04413357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04413357 about?
NCT04413357 is a clinical study titled "Glycemic Response in Persons with Type 2 Diabetes". This will be a randomized crossover design with nutrition supplement interventions.
What is the current status of trial NCT04413357?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-05-18. Estimated completion is 2020-08-11.
What interventions are being tested in trial NCT04413357?
The interventions under investigation include: Balanced Nutritional Drink (OTHER), Diabetes Specific, Balanced Nutritional Drink (DMA) (OTHER), Diabetes Specific, Balanced Nutritional Drink DMB (OTHER).
Who is sponsoring clinical trial NCT04413357?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.